Tarsus Pharmaceuticals (TARS US)

Analysis

Health Care • United States

Tarsus Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company develops drugs and therapies for treatment of blepharitis. Tarsus Pharmaceuticals serves patients in the United States.

Refresh

Focused

No publications yet

There aren’t any broker reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00